BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ryu JH, Yoon HY, Sun IC, Kwon IC, Kim K. Tumor-Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity. Adv Mater 2020;32:e2002197. [PMID: 33051905 DOI: 10.1002/adma.202002197] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen L, Hong W, Ren W, Xu T, Qian Z, He Z. Recent progress in targeted delivery vectors based on biomimetic nanoparticles. Signal Transduct Target Ther 2021;6:225. [PMID: 34099630 DOI: 10.1038/s41392-021-00631-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Ding J, Guo Y. Recent Advances in Chitosan and its Derivatives in Cancer Treatment. Front Pharmacol 2022;13:888740. [DOI: 10.3389/fphar.2022.888740] [Reference Citation Analysis]
3 Wang S, Li B, Zhang H, Chen J, Sun X, Xu J, Ren T, Zhang Y, Ma C, Guo W, Liu K. Improving Bioavailability of Hydrophobic Prodrugs through Supramolecular Nanocarriers Based on Recombinant Proteins for Osteosarcoma Treatment. Angew Chem 2021;133:11352-6. [DOI: 10.1002/ange.202101938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Su Y, Wu F, Song Q, Wu M, Mohammadniaei M, Zhang T, Liu B, Wu S, Zhang M, Li A, Shen J. Dual enzyme-mimic nanozyme based on single-atom construction strategy for photothermal-augmented nanocatalytic therapy in the second near-infrared biowindow. Biomaterials 2021;281:121325. [PMID: 34953332 DOI: 10.1016/j.biomaterials.2021.121325] [Reference Citation Analysis]
5 Alqosaibi AI. Nanocarriers for anticancer drugs: challenges and perspectives. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.103298] [Reference Citation Analysis]
6 Wu D, Yang K, Zhang Z, Feng Y, Rao L, Chen X, Yu G. Metal-free bioorthogonal click chemistry in cancer theranostics. Chem Soc Rev 2022. [PMID: 35050284 DOI: 10.1039/d1cs00451d] [Reference Citation Analysis]
7 Zhang T, Lin R, Wu H, Jiang X, Gao J. Mesenchymal stem cells: A living carrier for active tumor-targeted delivery. Adv Drug Deliv Rev 2022;185:114300. [PMID: 35447165 DOI: 10.1016/j.addr.2022.114300] [Reference Citation Analysis]
8 Lu Y, Liang L, Shen G, Yao W, Zhang C, Huang D, Xuan Z, Li J, Liu J. Theoretical investigation of Chitosan-Assisted Controlled Release of Digestive System Antitumor Drug Fluorouracil. J Pharm Sci 2022:S0022-3549(22)00044-2. [PMID: 35122829 DOI: 10.1016/j.xphs.2022.01.034] [Reference Citation Analysis]
9 Liang J, Zhao X. Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development. Cancer Biol Med 2021:j. [PMID: 33979069 DOI: 10.20892/j.issn.2095-3941.2021.0004] [Reference Citation Analysis]
10 Lee KW, Wan Y, Li X, Cui X, Li S, Lee CS. Recent Progress of Alkyl Radicals Generation-Based Agents for Biomedical Applications. Adv Healthc Mater 2021;10:e2100055. [PMID: 33738983 DOI: 10.1002/adhm.202100055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Wang X, Yuan Z, Tao A, Wang P, Xie W, Yang S, Huang J, Wen N. Hydrogel-based patient-friendly photodynamic therapy of oral potentially malignant disorders. Biomaterials 2022;281:121377. [DOI: 10.1016/j.biomaterials.2022.121377] [Reference Citation Analysis]
12 Jiang B, Hao D, Li C, Lu S, Pei Q, Xie Z. Fluorinated paclitaxel prodrugs for potentiated stability and chemotherapy. J Mater Chem B 2021;9:9971-9. [PMID: 34871339 DOI: 10.1039/d1tb02165f] [Reference Citation Analysis]
13 Cao S, Deng Y, Zhang L, Aleahmad M. Chitosan nanoparticles, as biological macromolecule-based drug delivery systems to improve the healing potential of artificial neural guidance channels: A review. Int J Biol Macromol 2022:S0141-8130(22)00018-6. [PMID: 35031319 DOI: 10.1016/j.ijbiomac.2022.01.017] [Reference Citation Analysis]
14 Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Drug release study of the chitosan-based nanoparticles. Heliyon 2022;8:e08674. [PMID: 35028457 DOI: 10.1016/j.heliyon.2021.e08674] [Reference Citation Analysis]
15 Chen Y, Zhang Q, Zhong Y, Wei P, Yu X, Huang J, Cai J. Super‐Strong and Super‐Stiff Chitosan Filaments with Highly Ordered Hierarchical Structure. Adv Funct Mater 2021;31:2104368. [DOI: 10.1002/adfm.202104368] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
16 Li X, Wang Y, Feng C, Chen H, Gao Y. Chemical Modification of Chitosan for Developing Cancer Nanotheranostics. Biomacromolecules 2022. [PMID: 35522524 DOI: 10.1021/acs.biomac.2c00184] [Reference Citation Analysis]
17 Liu X, Zhou H, Yu W, Xiong X, Krastev R, Ma X. Preparation of Cationic Amphiphilic Nanoparticles with Modified Chitosan Derivatives for Doxorubicin Delivery. Materials (Basel) 2021;14:7010. [PMID: 34832408 DOI: 10.3390/ma14227010] [Reference Citation Analysis]
18 Cai Y, Tang C, Wei Z, Song C, Zou H, Zhang G, Ran J, Han W. Fused-Ring Small-Molecule-Based Bathochromic Nano-agents for Tumor NIR-II Fluorescence Imaging-Guided Photothermal/Photodynamic Therapy. ACS Appl Bio Mater 2021;4:1942-9. [DOI: 10.1021/acsabm.0c01576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wang S, Li B, Zhang H, Chen J, Sun X, Xu J, Ren T, Zhang Y, Ma C, Guo W, Liu K. Improving Bioavailability of Hydrophobic Prodrugs through Supramolecular Nanocarriers Based on Recombinant Proteins for Osteosarcoma Treatment. Angew Chem Int Ed Engl 2021;60:11252-6. [PMID: 33650286 DOI: 10.1002/anie.202101938] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zhang Y, Wang G, Li Q, Jiang Y, Chen W, Zhao M, Liang G, Miao Q. Acidity-Activated Charge Conversion of 177Lu-Labeled Nanoagent for the Enhanced Photodynamic Radionuclide Therapy of Cancer. ACS Appl Mater Interfaces 2022;14:3875-84. [PMID: 35021621 DOI: 10.1021/acsami.1c21860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Du Y, Han M, Cao K, Li Q, Pang J, Dou L, Liu S, Shi Z, Yan F, Feng S. Gold Nanorods Exhibit Intrinsic Therapeutic Activity via Controlling N6-Methyladenosine-Based Epitranscriptomics in Acute Myeloid Leukemia. ACS Nano 2021. [PMID: 34694795 DOI: 10.1021/acsnano.1c05547] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
22 Wu J, Wang S, Liu S, Liu F, Zhou F. Immunoadjuvant Nanoparticles as Trojan Horses for Enhanced Photo-Immunotherapy in the Treatment of Triple-Negative Breast Cancer. Front Pharmacol 2022;13:883428. [DOI: 10.3389/fphar.2022.883428] [Reference Citation Analysis]
23 Mochizuki C, Nakamura J, Nakamura M. Development of Non-Porous Silica Nanoparticles towards Cancer Photo-Theranostics. Biomedicines 2021;9:73. [PMID: 33451074 DOI: 10.3390/biomedicines9010073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Xiao Y, Lu H, Shi C, Lei F, Rackemann D, Li K, Li W, Doherty WO. High-performance quaternary ammonium-functionalized chitosan/graphene oxide composite aerogel for remelt syrup decolorization in sugar refining. Chemical Engineering Journal 2022;428:132575. [DOI: 10.1016/j.cej.2021.132575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Zong X, Liu L, Yang H, Wu J, Yuan P, Chen X, Yang C, Li X, Li Y, Ji X, Shi C, Xue W, Dai J. Artificial Nanoplatelets Depend on Size for Precisely Inducing Thrombosis in Tumor Vessels. Small Methods 2022;:e2101474. [PMID: 35344282 DOI: 10.1002/smtd.202101474] [Reference Citation Analysis]